However, one neurologist recently published a paper on the vascular connection to MS, and said this:
"...vascular contributions in MS do appear to support the notion of the vasculature being an initiating target in MS etiology and not simply a bystander presentation of other disease processes. Perhaps the strongest support for this is the number of MS therapies that have been developed, which target leukocyte binding to activated endothelial cells, a central component of the blood-brain barrier (BBB)."
Here are drugs being developed by neurologists to address blood flow:
10. The ISNVD has been established. There is now an international society of researchers working on understanding the venous connection to neurovascular disease. Their fourth conference will be held in San Francisco in February, 2014. The International Society for Neurovascular Disease is convening, publishing, and moving this research forward.